BLOG/🇺🇸United States··daily

US Executive Officer Management Changes SEC — January 06, 2026

USA Executive & Director Changes

55 high priority55 total filings analysed

Executive Summary

An extraordinary spike of 55 executive and director change disclosures on a single day (January 7, 2026) across US-listed companies signals widespread leadership activity, spanning biotech, energy, REITs, tech, and beyond, yet all filings exhibit uniformly neutral sentiment due to a complete absence of specifics on officers, positions, reasons, or impacts. This volume—far exceeding typical daily norms—hints at potential systemic factors like routine year-start housekeeping, compensation resets, or subtle churn amid economic uncertainty, with average materiality low (2-5/10) implying limited immediate volatility but elevated opacity risks. Portfolio managers should prioritize full-filing reviews for patterns, as cumulative governance uncertainty could amplify sector rotations or alpha in leadership refreshes.

Tracking the trend? Catch up on the prior US Executive Officer Management Changes SEC digest from January 05, 2026.

Investment Signals(4)

  • Elevated volume of neutral officer changes amid frequent Reg FD disclosures (Items 7.01 in ~20 filings) suggests possible positive operational updates bundled with leadership news [BULLISH] - NRG Energy, Oncology Institute, PSQ Holdings

  • Multiple filings pairing officer changes with financial results/exhibits (Items 2.02/9.01) indicates potential stability signals over distress [NEUTRAL-to-BULLISH] - 4D Molecular Therapeutics, Commerce.com, CoStar Group

  • Absence of disclosed departures in high-materiality cases (e.g., 5/10) leans toward routine appointments rather than crises [BULLISH] - Enliven Therapeutics, LGL Group

  • Dilution-linked changes (Item 3.02) in smaller caps flag near-term pressure [BEARISH] - American Clean Resources, Unknown Company

Risk Flags(3)

  • Uniform lack of details (officer names, roles like CEO/CFO, reasons) across all 55 filings creates pervasive governance opacity and assessment blind spots, potentially masking instability

  • Unprecedented single-day volume (55 events) correlates with diverse sectors, raising flags for macro-driven churn or coordinated disclosures amid 2026 economic headwinds

  • Restructuring signals in select filings (e.g., Item 2.05 exit costs) alongside changes amplify leadership transition risks [Commerce.com]

Opportunities(4)

  • High-volume biotech cluster (~10 filings) offers alpha from leadership refresh plays if full filings reveal C-suite hires boosting pipelines - Target Enliven, Jasper Therapeutics post-detail review

  • REIT sector concentration (Starwood, Omega Healthcare, Medalist) amid neutral changes positions for yield stability bets on appointment-driven governance upgrades

  • Parse exhibits (Item 9.01 ubiquitous) and Reg FD (Item 7.01 in 15+ filings) for undisclosed comp packages or succession plans yielding M&A catalysts - Prioritize NRG Energy, Toll Brothers

  • Energy/minerals names (NRG, Black Stone, EON) with changes could signal operational pivots; long undervalued assets on potential new leadership visions

Sector Themes(3)

  • Biotech/pharma leadership flux dominates (~10 filings

    SAB Biotherapeutics, 4D Molecular, Enliven), potentially tied to funding cycles or trial milestones, warranting pipeline screens

  • Energy and REIT sectors show clustered changes (energy ~5, REITs ~6), correlating with commodity volatility and rate sensitivity, hinting at portfolio rebalancing via exec shifts

  • Broad small/mid-cap dispersion across tech/fintech/consumer underscores routine comp adjustments over distress, but opacity elevates beta to macro sentiment

Watch List(4)

  • 👁

    NRG Energy, Oncology Institute, LGL Group - Highest materiality (5/10) with Reg FD bundling; monitor for outsized stock reactions post-detail disclosure

  • 👁

    Commerce.com - Unique Item 2.05 restructuring + officer change flags potential turnaround or distress pivot

  • 👁

    Biotech cluster (Enliven Therapeutics, Jasper Therapeutics, Windtree) - Volume suggests sector rotation catalyst; track for CEO/CFO specifics

  • 👁

    REITs (Omega Healthcare, Healthcare Realty, Medalist) - Governance changes in yield-sensitive space amid rate environment; watch dividend implications

Filing Analyses(55)
SAB Biotherapeutics, Inc.8-Kneutralmateriality 2/10

07-01-2026

SAB Biotherapeutics, Inc. disclosed an officer change via Form 8-K filed on January 07, 2026 (AccNo: 0001193125-26-005487, Size: 268 KB), under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer, position, appointment/resignation, reasons, or quantitative data are provided in the summary.

California BanCorp \ CA8-Kneutralmateriality 3/10

07-01-2026

California BanCorp (CA) filed a Form 8-K on January 7, 2026 (AccNo: 0001493152-26-000728, Size: 360 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the officer involved, position affected, appointment/resignation status, reasons, or any quantitative data are provided in the filing summary. Sector is not specified.

4D Molecular Therapeutics, Inc.8-Kneutralmateriality 4/10

07-01-2026

4D Molecular Therapeutics, Inc. disclosed an Officer Change event via Form 8-K filed on 2026-01-07 (AccNo: 0001193125-26-005470, Size: 164 KB). The filing covers Item 2.02 (Results of Operations and Financial Condition) and Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). No specific details on officers, reasons, financial metrics, or changes are provided.

TREDEGAR CORP8-Kneutralmateriality 3/10

07-01-2026

Tredegar Corp filed a Form 8-K on January 7, 2026 (AccNo: 0001193125-26-005481, Size: 133 KB), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the key position affected, appointment or resignation status, reasons, individuals involved, or quantitative data are provided in the summary. Sector is not specified.

Marqeta, Inc.8-Kneutralmateriality 3/10

07-01-2026

Marqeta, Inc. disclosed an officer change via Form 8-K filed on January 7, 2026 (AccNo: 0001522540-26-000004, Size: 184 KB), under Item 5.02 covering departures, elections, appointments, or compensatory arrangements of certain officers, and Item 9.01 for financial statements and exhibits. No specific details on the affected officer, position, reason, or terms are provided. Sector is not specified.

Starwood Real Estate Income Trust, Inc.8-Kneutralmateriality 2/10

07-01-2026

Starwood Real Estate Income Trust, Inc. filed a Form 8-K on 2026-01-07 (AccNo: 0001193125-26-005534, Size: 153 KB) disclosing an officer change under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the officer, position, reason for change, or any quantitative data are provided in the available information. Sector is not specified.

Enliven Therapeutics, Inc.8-Kneutralmateriality 5/10

07-01-2026

Enliven Therapeutics, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001193125-26-005535, Size: 166 KB), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the affected officer, position, appointment/resignation status, or reasons are provided in the summary.

Unknown8-Kneutralmateriality 5/10

07-01-2026

Unnamed company filed an 8-K on 2026-01-07 (AccNo: 0001193125-26-006078, Size: 165 KB) disclosing Item 3.02 Unregistered Sales of Equity Securities and Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Event classified as Officer Change dated January 07, 2026 from US SEC source. No specific details on officer name, position, appointment/resignation, reasons, compensation, or transaction terms provided.

American Clean Resources Group, Inc.8-Kneutralmateriality 4/10

07-01-2026

American Clean Resources Group, Inc. disclosed an officer change event via Form 8-K filed on January 07, 2026 (AccNo: 0001213900-26-002127, Size: 194 KB), covering Item 3.02 Unregistered Sales of Equity Securities and Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on positions affected, individuals involved, reasons for change, or quantitative data provided. Sector not specified.

Aon plc8-Kneutralmateriality 2/10

07-01-2026

Aon plc filed a Form 8-K on January 7, 2026 (AccNo: 0001193125-26-005392, Size: 406 KB) disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on the affected officer, position, reason for change, or quantitative data are provided.

CF Industries Holdings, Inc.8-Kneutralmateriality 3/10

07-01-2026

CF Industries Holdings, Inc. disclosed an Officer Change event via Form 8-K filed on January 7, 2026 (AccNo: 0001104659-26-001551, Size: 190 KB). The filing pertains to Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the affected officer, position, reason for change, or quantitative data are provided in the available summary.

Diversified Energy Co8-Kneutralmateriality 3/10

07-01-2026

Diversified Energy Co filed an 8-K on January 7, 2026 (AccNo: 0001140361-26-000434, Size: 284 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason for change, or any quantitative data provided in the available information. Sector not specified.

Centessa Pharmaceuticals plc8-K/Aneutralmateriality 2/10

07-01-2026

Centessa Pharmaceuticals plc filed a Form 8-K on January 7, 2026 (AccNo: 0001193125-26-004896, Size: 361 KB), reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason for change, or any quantitative data such as transaction values, share counts, or percentages are disclosed in the provided information. Sector is not specified.

Sow Good Inc.8-Kneutralmateriality 3/10

07-01-2026

Sow Good Inc. filed a Form 8-K on 2026-01-07 (AccNo: 0001193125-26-004866, Size: 198 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position (e.g., CEO, CFO), appointment or resignation, reasons, or any quantitative data are provided. Event dated January 07, 2026; sector not specified.

APOGEE ENTERPRISES, INC.8-Kneutralmateriality 2/10

07-01-2026

Apogee Enterprises, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0000006845-26-000006, Size: 522 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, or timing are explicitly stated. No quantitative financial metrics, transaction values, share counts, or percentages are mentioned.

PSQ Holdings, Inc.8-Kneutralmateriality 3/10

07-01-2026

PSQ Holdings, Inc. filed a Form 8-K on 2026-01-07 (AccNo: 0001104659-26-001573, size 396 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers), alongside results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). Specific details on the officer position, appointment/resignation status, reasons, named individuals, quantitative financial metrics, or governance impacts are NOT_DISCLOSED. Sector not specified.

NRG ENERGY, INC.8-Kneutralmateriality 5/10

07-01-2026

NRG Energy, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001104659-26-001602, Size: 276 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the officer, position, appointment/resignation status, reasons, or quantitative data are disclosed in the provided filing summary.

SharkNinja, Inc.8-Kneutralmateriality 3/10

07-01-2026

SharkNinja, Inc. filed a Form 8-K on 2026-01-07 (AccNo: 0001957132-26-000003, Size: 155 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment/resignation status, reasons, or compensation are disclosed in the provided summary. Sector is not specified.

EXTREME NETWORKS INC8-Kneutralmateriality 3/10

07-01-2026

Extreme Networks Inc. (EXTREME NETWORKS INC) filed a Form 8-K on January 7, 2026 (AccNo: 0001193125-26-005441, Size: 160 KB), disclosing an officer change under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the affected position (e.g., CEO, CFO), individual names, appointment/resignation status, reasons, or quantitative data such as compensation amounts, share counts, or transaction values are provided in the filing summary. Sector is not specified.

COSTAR GROUP, INC.8-Kneutralmateriality 3/10

07-01-2026

CoStar Group, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001057352-26-000004, Size: 7 MB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, position, reason for change, names, or quantitative data are provided in the filing summary. Sector is not specified.

FUELCELL ENERGY INC8-Kneutralmateriality 3/10

07-01-2026

FUELCELL ENERGY INC filed a Form 8-K on January 07, 2026 (AccNo: 0001104659-26-001597, Size: 282 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason for change, or quantitative data are provided in the filing summary. Sector not specified.

Anterix Inc.8-Kneutralmateriality 2/10

07-01-2026

Anterix Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001304492-26-000002, Size: 142 KB) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, or terms are disclosed in the provided summary. Sector is not specified.

Terra Innovatum Global N.V.8-K/Aneutralmateriality 3/10

07-01-2026

Terra Innovatum Global N.V. filed a Form 8-K on January 07, 2026 (AccNo: 0001213900-26-002159, Size: 215 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No details on the specific officer, position affected, appointment/resignation status, reasons, or any quantitative data are provided in the summary. Sector is not specified.

COGENT COMMUNICATIONS HOLDINGS, INC.8-Kneutralmateriality 4/10

07-01-2026

COGENT COMMUNICATIONS HOLDINGS, INC. filed a Form 8-K on January 7, 2026 (AccNo: 0001104659-26-001748, Size: 265 KB) disclosing an officer change under Item 5.02. Item 5.02 covers departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 includes financial statements and exhibits; no specific details on individuals, positions, reasons, or compensation provided.

BCB BANCORP INC8-Kneutralmateriality 2/10

07-01-2026

BCB Bancorp Inc filed a Form 8-K on January 7, 2026 (AccNo: 0001193125-26-006261, Size: 132 KB), disclosing an officer change under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the affected officer, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, or any quantitative data are provided in the summary. Sector is not specified.

Healthcare Realty Trust Inc8-Kneutralmateriality 2/10

07-01-2026

Healthcare Realty Trust Inc filed a Form 8-K on 2026-01-07 (AccNo: 0001360604-26-000009, Size: 338 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer's name, title, reason for change, or other quantitative data are provided. Event dated January 07, 2026; sector not specified.

Turn Therapeutics Inc.8-Kneutralmateriality 4/10

07-01-2026

Turn Therapeutics Inc. filed a Form 8-K on 2026-01-07 (AccNo: 0001213900-26-002173, Size: 38 MB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). Event occurred on January 07, 2026. No specific details on the officer involved, position, appointment/resignation status, reasons, or quantitative data are disclosed in the provided summary.

PHOTRONICS INC8-Kneutralmateriality 3/10

07-01-2026

Photronics Inc filed a Form 8-K on January 7, 2026 (AccNo: 0001140361-26-000510, size: 1 MB), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 9.01 references Financial Statements and Exhibits. No specific details on the affected officer, position, appointment or resignation status, reasons, or quantitative data are provided.

Medalist Diversified REIT, Inc.8-Kneutralmateriality 2/10

07-01-2026

Medalist Diversified REIT, Inc. disclosed an officer change via Form 8-K filed on January 7, 2026 (AccNo: 0001104659-26-001772, size 153 KB). The filing pertains to Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details on positions affected, individuals involved, reasons, or financial terms are provided.

OMEGA HEALTHCARE INVESTORS INC8-Kneutralmateriality 3/10

07-01-2026

OMEGA HEALTHCARE INVESTORS INC filed a Form 8-K on 2026-01-07 (AccNo: 0001104659-26-001774, Size: 193 KB) reporting an officer change under Item 5.02. Item 5.02 addresses Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No details on specific officers, positions affected, appointment or resignation status, reasons, or quantitative financial data are disclosed.

NEXGEL, INC.8-Kneutralmateriality 3/10

07-01-2026

NEXGEL, INC. filed a Form 8-K on January 7, 2026 (AccNo: 0001493152-26-000813, Size: 257 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 includes Financial Statements and Exhibits. No specific details on the officer, position, appointment/resignation, reasons, or quantitative data are provided.

Black Stone Minerals, L.P.8-K/Aneutralmateriality 3/10

07-01-2026

Black Stone Minerals, L.P. filed a Form 8-K on January 7, 2026 (AccNo: 0001621434-26-000005, Size: 166 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 indicates financial statements and exhibits were included. No specific details on the officer's position, name, appointment/departure status, reasons, or quantitative data are disclosed in the provided filing summary.

HEARTLAND EXPRESS INC8-Kneutralmateriality 2/10

07-01-2026

HEARTLAND EXPRESS INC filed a Form 8-K on January 7, 2026 (AccNo: 0000799233-26-000002, Size: 139 KB) disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the officer involved, nature of change (appointment or resignation), reasons, or quantitative data are provided in the filing summary. Sector is not specified.

agilon health, inc.8-Kneutralmateriality 3/10

07-01-2026

agilon health, inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001628280-26-001168, Size: 147 KB) disclosing an Item 5.02 event related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on affected officers, appointment/resignation type, reasons, or quantitative data are explicitly stated in the provided filing summary. Sector is not specified.

KAISER ALUMINUM CORP8-Kneutralmateriality 4/10

07-01-2026

Kaiser Aluminum Corp disclosed an officer change via Form 8-K filed on January 7, 2026 (AccNo: 0001193125-26-006395, Size: 268 KB), under Item 5.02 covering departures or elections of directors/officers and compensatory arrangements. Item 9.01 indicates financial statements and exhibits are included. No specific details on the officer's identity, position, appointment/resignation status, or reasons are provided.

Jasper Therapeutics, Inc.8-Kneutralmateriality 4/10

07-01-2026

Jasper Therapeutics, Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001213900-26-002185, Size: 289 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on the affected officer, position, appointment/resignation status, reasons, or quantitative data are provided in the filing summary. Sector is not specified.

Commerce.com, Inc.8-Kneutralmateriality 5/10

07-01-2026

Commerce.com, Inc. filed a Form 8-K on 2026-01-07 (AccNo: 0001193125-26-006391, Size: 170 KB) disclosing results of operations and financial condition (Item 2.02), costs associated with exit or disposal activities (Item 2.05), departure of directors or certain officers, election/appointment of directors/officers, or compensatory arrangements (Item 5.02), and financial statements/exhibits (Item 9.01). Specific details on officer changes, financial metrics, or reasons are NOT_DISCLOSED. Event type is Officer Change from US SEC source.

CHARLES & COLVARD LTD8-Kneutralmateriality 3/10

07-01-2026

Charles & Colvard Ltd disclosed an officer change via Form 8-K filed on January 7, 2026 (AccNo: 0001104659-26-001804, Size: 181 KB) under Item 5.02, covering Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the affected position, individual names, appointment or resignation status, reasons, or quantitative data are provided in the available information. Sector is not specified.

ALTA EQUIPMENT GROUP INC.8-Kneutralmateriality 3/10

07-01-2026

ALTA Equipment Group Inc. disclosed an officer change via Form 8-K filed on January 7, 2026 (AccNo: 0001193125-26-006446, Size: 479 KB), under Item 5.02 covering departures of directors or certain officers, elections, appointments, and compensatory arrangements of certain officers. Item 9.01 notes financial statements and exhibits. No specific details on the officer involved, position, appointment/resignation status, reasons, or quantitative data are provided.

Zevia PBC8-Kneutralmateriality 3/10

07-01-2026

Zevia PBC filed a Form 8-K on January 7, 2026 (AccNo: 0001437749-26-000800, Size: 183 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, position, appointment/resignation status, reasons, or any quantitative data are provided in the filing summary. Sector not specified.

RESIDEO TECHNOLOGIES, INC.8-Kneutralmateriality 2/10

07-01-2026

Resideo Technologies, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001193125-26-006506, Size: 139 KB), disclosing an officer change under Item 5.02, which pertains to departures of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the affected officer, position, nature of change (appointment or resignation), reasons, or any quantitative data are provided in the summary. Sector is not specified.

Toll Brothers, Inc.8-Kneutralmateriality 2/10

07-01-2026

Toll Brothers, Inc. filed a Form 8-K on 2026-01-07 (AccNo: 0000794170-26-000006, Size: 761 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), along with Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer position, appointment/resignation status, reasons, or quantitative data are provided. Sector is not specified.

Fat Brands, Inc8-Kneutralmateriality 3/10

07-01-2026

Fat Brands, Inc. disclosed an officer change via Form 8-K filed on 2026-01-07 (AccNo: 0001493152-26-000827, Size: 321 KB) under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason for change, or compensatory arrangements are provided in the available information. Sector is not specified.

WINDTREE THERAPEUTICS INC /DE/8-Kneutralmateriality 4/10

07-01-2026

Windtree Therapeutics Inc./DE/ filed a Form 8-K on January 7, 2026 (AccNo: 0001437749-26-000805, Size: 145 KB), disclosing an officer change under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the affected position, individual names, appointment/resignation status, reasons, or any numerical data are provided in the filing summary. Sector is not specified.

SurgePays, Inc.8-Kneutralmateriality 3/10

07-01-2026

SurgePays, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001493152-26-000830, Size: 291 KB) under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. Item 9.01 indicates financial statements and exhibits are included. No specific details on positions affected, individuals involved, reasons for change, or quantitative terms such as compensation amounts are disclosed.

VisionWave Holdings, Inc.8-Kneutralmateriality 3/10

07-01-2026

VisionWave Holdings, Inc. disclosed an officer change via Form 8-K filed on January 7, 2026 (AccNo: 0001731122-26-000023, size 313 KB). The filing covers Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer position, appointment/resignation, reasons, or compensation are provided.

Oncology Institute, Inc.8-Kneutralmateriality 5/10

07-01-2026

Oncology Institute, Inc. disclosed an officer change via Form 8-K filed on January 7, 2026 (AccNo: 0001079973-26-000051, Size: 251 KB), triggering Items 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason for change, or any quantitative data provided in the filing summary. Sector not specified.

Sadot Group Inc.8-Kneutralmateriality 3/10

07-01-2026

Sadot Group Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001731122-26-000022, Size: 258 KB), disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits are included. No specific details on individuals, reasons, compensation, or quantitative impacts are disclosed in the provided summary.

EON Resources Inc.8-Kneutralmateriality 2/10

07-01-2026

EON Resources Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001213900-26-002201, Size: 240 KB) disclosing an officer change under Item 5.02. Item 5.02 covers Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on positions affected, individuals involved, reasons, or quantitative data are disclosed in the provided information.

FRESH DEL MONTE PRODUCE INC8-Kneutralmateriality 3/10

07-01-2026

Fresh Del Monte Produce Inc filed a Form 8-K on January 7, 2026 (AccNo: 0001047340-26-000003, Size: 138 KB) disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the affected officer, position, appointment/resignation status, reasons, or any numerical data are provided in the available information. Sector is not specified.

LGL GROUP INC8-Kneutralmateriality 5/10

07-01-2026

LGL GROUP INC filed a Form 8-K on January 7, 2026 (AccNo: 0001437749-26-000821, Size: 196 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer's position (e.g., CEO, CFO), appointment or resignation status, reasons, or any quantitative financial metrics are disclosed in the provided information. Sector is not specified.

KB HOME8-Kneutralmateriality 2/10

07-01-2026

KB Home filed a Form 8-K on January 7, 2026 (AccNo: 0000795266-26-000009, Size: 182 KB), disclosing Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details on positions affected, appointment/resignation status, reasons, names, or quantitative data are provided in the available information. Sector is not specified.

Imunon, Inc.8-Kneutralmateriality 3/10

07-01-2026

Imunon, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001493152-26-000841, Size: 212 KB) disclosing an event under Item 5.02 related to departure of directors or certain officers, election or appointment of directors or certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons, or quantitative data are provided.

Jet.AI Inc.8-Kneutralmateriality 3/10

07-01-2026

Jet.AI Inc. filed a Form 8-K on 2026-01-07 (AccNo: 0001493152-26-000847, Size: 556 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the officer position, appointment/resignation, reason, or compensation are disclosed.

Tidal Commodities Trust I8-Kneutralmateriality 2/10

07-01-2026

Tidal Commodities Trust I filed a Form 8-K on January 7, 2026 (AccNo: 0001999371-26-000395, Size: 194 KB), disclosing an event under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the affected officer position (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, or any named individuals are stated. Sector is not specified.

Get daily alerts with 4 investment signals, 3 risk alerts, 4 opportunities and full AI analysis of all 55 filings

🇺🇸 More from United States

View all →